All News PeptiDream Inc.

Equities

4587

JP3836750004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-30 am EDT			5-day change	1st Jan Change
2,022 ^JPY	+24.66%		+33.25%	+36.02%

01:00pm	Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	CI
01:00pm	PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis	07:05am	BU
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	07:00am	CI
PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG	07:00am	CI
Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	Mar. 12	CI
Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	Mar. 12	CI
Certain Common Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	Mar. 12	CI
PeptiDream to Partake in Bristol Myers' Tender Offer for All RayzeBio Shares	Feb. 15	MT
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	Feb. 14	CI
PeptiDream Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Jefferies Adjusts PeptiDream's Price Target to 1,400 Yen From 1,300 Yen, Keeps at Hold	Jan. 24	MT
Linqmed Inc. announced that it has received ¥680 million in funding from a group of investors	Dec. 21	CI
PeptiDream Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 09	CI
PeptiDream : Corporate Presentation（November 2023, English version)(2MB)	Nov. 01	PU
PeptiDream : コーポレート・プレゼンテーション(2023年11月、英語版）(2MB)	Nov. 01	PU
Jefferies Downgrades PeptiDream to Hold From Buy, Adjusts Price Target to 1,300 Yen From 1,600 Yen	23-10-27	MT
PeptiDream and Bristol-Myers Squibb to Explore Alternatives as PDL1 Program Faces Setback	23-10-27	MT
Peptidream Announces Update on PDL1 Program Partnered with Bristol-Myers Squibb Company	23-10-26	CI
Jefferies Upgrades PeptiDream to Buy From Hold, Adjusts Price Target to 1,600 Yen From 1,900 Yen	23-10-18	MT
PeptiDream : Sustainability Report 2023(2.9 MB)	23-09-27	PU
PeptiDream Announces Initial Public Offering of RayzeBio and Update on GPC3 Program	23-09-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News PeptiDream Inc.

Equities

4587

JP3836750004

All News

Filters